Skip to content

About Dr Simon Tavernor

Dr Tavernor is a Fellow of the Royal College of Psychiatrists and from 2005 he has worked at Mersey Care NHS Foundation Trust, within the Arundel House Community Mental Health Team.  He was a Clinical Director from 2007 to 2019 and Associate Medical Director (Physical Health & Medicines Safety), the medicine safety officer and Controlled Drugs Accountable Officer from 2014 to 2018.  From 2005 until 2018, prior to taking on the role of Supra Theme Lead at the School of Medicine, he was the Undergraduate Clinical Sub-dean for Psychiatry at Liverpool University.


Involvement with medical undergraduate teaching at Liverpool University since 2005 and as Clinical Lecturer in Psychiatry at Nottingham University from 1997 to 1999.  Experience of postgraduate psychiatric education, supervising both junior and senior trainees. 

External examiner at Southampton University for Year 4 of their Medical Course since 2019.


Dr Tavernor has research experience within psychopharmacolgy, epilepsy and forensic psychiatry. 

He is a Research & Scholarship supervisor within the School of Medicine, University of Liverpool.

His current research interests are in medical undergraduate wellbeing and Global Mental Health.

Published Work


Tavernor,S., Abduljawad,K., Langley,R., Bradshaw,C., Szabadi,E.  “Effects of pentagastrin and the cold pressor test on the acoustic startle response and pupillary function in man.”  Journal of Psychopharmacology 2000;14(4):387-394. (Research supported partially by an educational award from Merck Lipha, administered through the midlands division of the Royal College of Psychiatrists)

Tavernor, R., Tavernor, S., Swinton, M.  “High dose antipsychotic medication in maximum security.”  J Forensic Psychiatry 2000;11(1):36-48.

Szabadi, E., Tavernor, S.  “Hypo- and Hypersalivation Induced by Psychoactive Drugs: Incidence, Mechanisms and Therapeutic Implications”  CNS Drugs 1999;11(6):449-466.

Bitsios, P., Langley, R., Tavernor, S., Pyykko, K., Scheinin, M., Szabadi, E., Bradshaw, C.  “Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man”  Br J Clin Pharmacol 1998;45:551-558.

Wong, I., Tavernor, S., Tavernor, R.  “Psychiatric Adverse Effects of Anticonvulsant Drugs: Incidence and Therapeutic Implications”  CNS Drugs 1997;8(6):492-509.

Tavernor, R., Tavernor S., & Crispin, Z.  "Influence of sudden ward environmental change on psychosocial functioning in psychopathically disordered special hospital patients.” J. Forensic Psychiatry 1996; 7(2): 393-399

Tavernor, S., Brown, S., Tavernor, R., Gifford, C. "Electrocardiographic lengthening associated with epileptiform EEG discharges-a role in Sudden Unexplained Death in Epilepsy?", Seizure 1996; 5 :79-83.

Tavernor,S.J.  "MRCPsych: Part II Examination MCQs"  Br.J.Hosp.Med. 1995; 54(11):567-570.

Tavernor, S.J.,Wong, I.C.K.,Newton, R. & Brown,S.W.   "Rechallenge with Lamotrigine after initial rash." Seizure 1995;4:67-71.



Da Costa, A., Tavernor, S.  ‘Physical Health Monitoring in patients with Schizophrenia’  Presented at International Congress of the Royal College of Psychiatrists 2016, ExCeL, London, UK, 27-30 June 2016.

Raffi, R., Mahmood, J., Tavernor,S.  ‘The Impact of Ethnicity and Language Needs on Duration of Admission to a Psychiatric Inpatient Unit’  Presented at 18th European Congress of Psychiatry 27/2/10-2/3/10, Munich, Germany.  [European Psychiatry 2010;25(suppl 1):1489]

Malik, M., Tavernor, S.  ‘Recovery and Progress Clinic; A Pilot Study in the Realm of New Ways of Working for Urban General Adult Psychiatrists’  Presented at XIV World Congress of Psychiatry , Prague, Czech Republic, 20-25 September 2008.

Upton, I., Natajaran, P., Tavernor, S., Brabbins, C.  ‘Are Out-Patient Appointments Really Necessary?:- An Audit of the Treating Clinicians Opinion’  Presented at the Royal College of Psychiatrists Joint Residential Meeting of the Faculties of General Psychiatry and Rehabilitation and Social Psychiatry, 19-20 October 2006

Tavernor, S., Abduljawad, K., Langley, R., Bradshaw, C., Szabadi, E.  “Effect of Pentagastrin on the Pupil and Cardiovascular functions in healthy volunteers”  Presented at a meeting of the British Pharmacological Society, Brighton, U.K., 1999. [British Journal of Pharmacology, proceedings supplement.]

Abduljawad, K., Tavernor, S., Langley, R., Bradshaw, C., Szabadi, E.  “Effects of Pentagastrin and the Cold Pressor Test on the Acoustic Startle Response in Man”  Presented at the Summer Meeting of the British Association for Psychopharmacology, Cambridge, U.K., 1998.  [Journal of Psychopharmacology 1998; 12(3) Supplement A: A24.]

Bitsios, P., Langley, R.,Tavernor, S., Szabadi, E., Bradshaw,C.  “Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man”  Presented at the Proceedings of the British Pharmacological Society, Brighton, U.K., 1996. [British Journal of Pharmacology, proceedings supplement.]

Tavernor, S., Tavernor, R., Crawford, R., Brown, S.  “Clinical, Neuropsychological, Neurophysiological, and Neuroimaging Aspects of Psychosis in Epilepsy”  Presented at the 21st International Epilepsy Congress, Sydney, Australia, 1995.[Epilepsia 1995;36(suppl 3):178]  

Tavernor, R., Tavernor, S., Crispin, Z.  “Influence of Sudden Ward Environmental Change on Psychosocial Functioning in Psychopathically Disordered Special Hospital Patients”  Presented at the Royal College of Psychiatrists Annual Meeting of the Forensic Section, Eire, 1995.

Tavernor, S., Gifford, C., Owen, L., Medagoda, A., Brown, S.  “Electrocardiographic and Clinical Study of Sudden Unexplained Death in Epilepsy.”  Presented at the European Congress of Epileptology, Oporto, Portugal, 1994.[Epilepsia 1994;35(suppl 7):22]

Tavernor, S., Newton, E., Brown, S. “Rechallenge with Lamotrigine After Initial Rash”  Presented at the European Congress of Epileptology, Oporto, Portugal, 1994.[Epilepsia 1994;35(suppl 7):72]


  • F.R.C.Psych.  (2012)
  • M.R.C.Psych. (1993)
  • M.B. Ch.B.      (1987)
  • B.Med. Sc.     (1985)